Published in J Infect Dis on January 01, 1989
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet (2014) 2.35
Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol (1996) 2.25
Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol (1997) 1.96
Development of an adult mouse model for studies on protection against rotavirus. J Virol (1990) 1.72
Immunology of gut mucosal vaccines. Immunol Rev (2011) 1.59
Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol (1998) 1.23
Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol (1990) 1.23
Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bull World Health Organ (1996) 1.22
Rotavirus vaccines: an overview. Clin Microbiol Rev (1996) 1.19
Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J Virol (2005) 1.15
Serologic and mucosal immune response to rotavirus infection in the rabbit model. J Virol (1991) 1.01
Immune response of children who develop persistent diarrhea following rotavirus infection. Clin Diagn Lab Immunol (1999) 0.99
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. Clin Diagn Lab Immunol (1994) 0.96
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis (2013) 0.90
Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine. Hum Vaccin Immunother (2013) 0.87
Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother (2014) 0.87
Rotavirus-specific T-cell responses in young prospectively followed-up children. Clin Exp Immunol (2004) 0.87
Protective immunity to rotavirus shedding in the absence of interleukin-6: Th1 cells and immunoglobulin A develop normally. J Virol (2000) 0.86
Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa. AIDS (2017) 0.84
Measurement of rotavirus-neutralizing coproantibody in children by fluorescent focus reduction assay. J Clin Microbiol (1990) 0.84
Why does the world need another rotavirus vaccine? Ther Clin Risk Manag (2008) 0.83
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. Hum Vaccin Immunother (2014) 0.83
Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial. J Infect Dis (2016) 0.79
Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4. J Infect Dis (2009) 0.78
A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein. J Virol Methods (2012) 0.76
ROTAVAC(®) does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial. Heliyon (2017) 0.76
Effect of human rotavirus vaccine on severe diarrhea in African infants. Malawi Med J (2016) 0.75
Protective levels of intestinal rotavirus antibodies. J Infect Dis (1990) 0.75
Changes in anti-group a rotavirus antibody seroprevalence and levels in the Western Gyeongnam province of Korea over 16 years. J Korean Med Sci (2013) 0.75
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke (1998) 4.93
Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study. J Thromb Haemost (2014) 3.90
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Giant spin-orbit bowing in GaAs1-xBix. Phys Rev Lett (2006) 3.38
Failure of a single-headed kinesin to track parallel to microtubule protofilaments. Nature (1995) 3.16
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Coupling of kinesin steps to ATP hydrolysis. Nature (1997) 3.02
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Modified eggs are compatible with a diet that reduces serum cholesterol concentrations in humans. J Nutr (1992) 2.66
Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology (1997) 2.37
Choosing and using services for sexual health: a qualitative study of women's views. Sex Transm Infect (2001) 2.36
T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol (1998) 2.31
High resolution microendoscopy for classification of colorectal polyps. Endoscopy (2013) 2.29
Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol (2005) 2.28
Adrenal tumor complicating untreated 21-hydroxylase deficiency in a 5 1/2-year-old boy. Am J Dis Child (1993) 2.18
Preferential use of EPTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg (1990) 2.07
Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05
Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology (1995) 1.86
Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med (1995) 1.80
Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics (1996) 1.77
Development of an adult mouse model for studies on protection against rotavirus. J Virol (1990) 1.72
Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis (1987) 1.68
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J (1999) 1.64
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J Infect Dis (1999) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br J Obstet Gynaecol (1999) 1.59
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. J Infect Dis (1997) 1.57
Allergic reactions to workplace allergens. JAMA (1997) 1.57
The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection. Sex Transm Infect (2006) 1.56
Evaluation of a possible association of urban air toxics and asthma. Environ Health Perspect (1995) 1.52
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. Neurology (2011) 1.52
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother (2000) 1.49
Use of a holding technique to control the violent behavior of seriously disturbed adolescents. Hosp Community Psychiatry (1989) 1.48
Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis. Allergy (1999) 1.45
Evaluation of occupational asthma from airborne egg protein exposure in multiple settings. Chest (1990) 1.45
House dust (1-3)-beta-D-glucan and wheezing in infants. Allergy (2007) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology (1995) 1.36
Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res (1991) 1.36
C-Linker of cyclic nucleotide-gated channels controls coupling of ligand binding to channel gating. J Gen Physiol (1999) 1.35
GP's management of genital Chlamydia: a survey of reported practice. Fam Pract (1997) 1.35
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines. Cancer Res (1988) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J Infect Dis (1999) 1.32
Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol (1988) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Association of caesarean delivery for first birth with placenta praevia and placental abruption in second pregnancy. BJOG (2007) 1.26
Mediastinal and supraclavicular lymphadenitis and pneumonitis due to Chlamydia trachomatis serovars L1 and L2. N Engl J Med (1984) 1.25
Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect (2005) 1.24
Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. J Infect Dis (2001) 1.23
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol (1991) 1.22
Use of a computerized postural sway measurement system for neurobehavioral toxicology. Neurotoxicol Teratol (1990) 1.22
Large-scale purification of myeloperoxidase from HL60 promyelocytic cells: characterization and comparison to human neutrophil myeloperoxidase. Protein Expr Purif (2000) 1.22
Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis (1997) 1.22
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis (1993) 1.21
Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J Neurochem (1998) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis (1998) 1.18
A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines. J Allergy Clin Immunol (1994) 1.17
Brainstem auditory evoked response in newborns with hyperbilirubinemia. Indian Pediatr (1998) 1.17
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Imaging haemodynamic changes related to seizures: comparison of EEG-based general linear model, independent component analysis of fMRI and intracranial EEG. Neuroimage (2010) 1.16
Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology (1992) 1.14
Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc (1999) 1.14
Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis (2000) 1.14
Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob Agents Chemother (1994) 1.14
Predictors of stroke in patients of tuberculous meningitis and its effect on the outcome. QJM (2010) 1.13
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis (1984) 1.13
Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis (1995) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children. Gastroenterology (1988) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
The natural history of adult asthma: what do we know? Ann Allergy Asthma Immunol (2000) 1.10
Zosteriform spread of herpes simplex virus type 2 genital infection in the guinea-pig. J Gen Virol (1986) 1.09
Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized. J Pediatr (1982) 1.09
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol (1987) 1.08
The neurobehavioral effects of early lead exposure. Monogr Am Assoc Ment Defic (1987) 1.08